Borgna-Pignatti C: Modern treatment of thalassaemia intermedia. Br J Haematol. 2007, 138: 291-304. 10.1111/j.1365-2141.2007.06654.x.
Article
CAS
PubMed
Google Scholar
Borgna-Pignatti C, Marsella M, Zanforlin N: The natural history of thalassemia intermedia. Ann N Y Acad Sci. 2010, 1202: 214-220. 10.1111/j.1749-6632.2010.05550.x.
Article
PubMed
Google Scholar
Taher AT, Musallam KM, Cappellini MD, Weatherall DJ: Optimal management of beta thalassaemia intermedia. Br J Haematol. 2011, 152: 512-523. 10.1111/j.1365-2141.2010.08486.x.
Article
CAS
PubMed
Google Scholar
Weatherall DJ: The definition and epidemiology of non-transfusion-dependent thalassemia. Blood Rev. 2012, 26 (Suppl 1): S3-S6. 10.1016/S0268-960X(12)70003-6.
Article
PubMed
Google Scholar
Galanello R, Origa R: Beta-thalassemia. Orphanet J Rare Dis. 2010, 5: 11-10.1186/1750-1172-5-11.
Article
PubMed
PubMed Central
Google Scholar
Harteveld CL, Higgs DR: Alpha-thalassaemia. Orphanet J Rare Dis. 2010, 5: 13-10.1186/1750-1172-5-13.
Article
PubMed
PubMed Central
Google Scholar
Muncie HL, Campbell J: Alpha and beta thalassemia. Am Fam Physician. 2009, 80: 339-344.
PubMed
Google Scholar
Higgs DR, Thein SL, Wood WG: Distribution and population genetics of the thalassaemias. The Thalassemia Syndromes. Edited by: Weatherall DJ, Clegg JB. 2001, Blackwell Science, Ltd, London, 237-284.
Google Scholar
Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, Wajcman H, Hardison RC: Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res. 2004, 32: D537-D541. 10.1093/nar/gkh006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Viprakasit V, Lee-Lee C, Chong QT, Lin KH, Khuhapinant A: Iron chelation therapy in the management of thalassemia: the Asian perspectives. Int J Hematol. 2009, 90: 435-445. 10.1007/s12185-009-0432-0.
Article
CAS
PubMed
Google Scholar
Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001, 79: 704-712.
Weatherall DJ: The inherited diseases of hemoglobin are an emerging global health burden. Blood. 2010, 115: 4331-4336. 10.1182/blood-2010-01-251348.
Article
CAS
PubMed
PubMed Central
Google Scholar
Weatherall DJ: Genetic variation and susceptibility to infection: the red cell and malaria. Br J Haematol. 2008, 141: 276-286. 10.1111/j.1365-2141.2008.07085.x.
Article
CAS
PubMed
Google Scholar
Galanello R, Cao A: Relationship between genotype and phenotype: thalassemia intermedia. Ann N Y Acad Sci. 1998, 850: 325-333. 10.1111/j.1749-6632.1998.tb10489.x.
Article
CAS
PubMed
Google Scholar
Thein SL: Genetic insights into the clinical diversity of beta thalassaemia. Br J Haematol. 2004, 124: 264-274. 10.1046/j.1365-2141.2003.04769.x.
Article
CAS
PubMed
Google Scholar
Fucharoen S, Ketvichit P, Pootrakul P, Siritanaratkul N, Piankijagum A, Wasi P: Clinical manifestation of beta-thalassemia/hemoglobin E disease. J Pediatr Hematol Oncol. 2000, 22: 552-557. 10.1097/00043426-200011000-00022.
Article
CAS
PubMed
Google Scholar
Lai ME, Vacquer S, Carta MP, Spiga A, Cocco P, Angius F, Mandas A, Dessi S: Thalassemia intermedia is associated with a proatherogenic biochemical phenotype. Blood Cells Mol Dis. 2011, 46: 294-299. 10.1016/j.bcmd.2011.02.004.
Article
CAS
PubMed
Google Scholar
Lal A, Goldrich ML, Haines DA, Azimi M, Singer ST, Vichinsky EP: Heterogeneity of hemoglobin H disease in childhood. N Engl J Med. 2011, 364: 710-718. 10.1056/NEJMoa1010174.
Article
CAS
PubMed
Google Scholar
Musallam KM, Taher AT, Rachmilewitz EA: Beta-thalassemia intermedia: a clinical perspective. Cold Spring Harb Perspect Med. 2012, 2: a013482-10.1101/cshperspect.a013482.
Article
PubMed
PubMed Central
Google Scholar
Taher A, Isma’eel H, Cappellini MD: Thalassemia intermedia: revisited. Blood Cells Mol Dis. 2006, 37: 12-20. 10.1016/j.bcmd.2006.04.005.
Article
CAS
PubMed
Google Scholar
Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned MS, El-Chafic AH, Fasulo MR, Cappellini MD: Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study. Blood. 2010, 115: 1886-1892. 10.1182/blood-2009-09-243154.
Article
CAS
PubMed
Google Scholar
Rivella S: The role of ineffective erythropoiesis in non-transfusion dependent thalassemia. Blood Rev. 2012, 26 (Suppl 1): S12-S15. 10.1016/S0268-960X(12)70005-X.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rivella S: Ineffective erythropoiesis and thalassemias. Curr Opin Hematol. 2009, 16: 187-194. 10.1097/MOH.0b013e32832990a4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Olivieri NF, Weatherall DJ: Clinical aspects of B-thalassemia. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Edited by: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ. 2009, Cambridge University Press, Cambridge
Google Scholar
Olivieri NF: The beta-thalassemias. N Engl J Med. 1999, 341: 99-109. 10.1056/NEJM199907083410207.
Article
CAS
PubMed
Google Scholar
Taher AT, Musallam KM, El-Beshlawy A, Karimi M, Daar S, Belhoul K, Saned MS, Graziadei G, Cappellini MD: Age-related complications in treatment-naive patients with thalassaemia intermedia. Br J Haematol. 2010, 150: 486-489.
PubMed
Google Scholar
Doulgeraki A, Athanasopoulou H, Voskaki I, Tzagaraki A, Karabatsos F, Fragodimitri C, Georgakopoulou E, Iousef J, Monopolis I, Chatziliami A, Karagiorga M: Bone health evaluation of children and adolescents with homozygous beta-thalassemia: implications for practice. J Pediatr Hematol Oncol. 2012, 34: 344-348. 10.1097/MPH.0b013e3182431ddb.
Article
CAS
PubMed
Google Scholar
Pirinccioglu AG, Akpolat V, Koksal O, Haspolat K, Soker M: Bone mineral density in children with beta-thalassemia major in Diyarbakir. Bone. 2011, 49: 819-823. 10.1016/j.bone.2011.07.014.
Article
PubMed
Google Scholar
Vogiatzi MG, Macklin EA, Fung EB, Cheung AM, Vichinsky E, Olivieri N, Kirby M, Kwiatkowski JL, Cunningham M, Holm IA, Lane J, Schneider R, Fleisher M, Grady RW, Peterson CC, Giardina PJ: Bone disease in thalassemia: a frequent and still unresolved problem. J Bone Miner Res. 2009, 24: 543-557. 10.1359/jbmr.080505.
Article
PubMed
PubMed Central
Google Scholar
Pippard MJ, Callender ST, Warner GT, Weatherall DJ: Iron absorption and loading in beta-thalassaemia intermedia. Lancet. 1979, 2: 819-821. 10.1016/S0140-6736(79)92175-5.
Article
CAS
PubMed
Google Scholar
Pootrakul P, Kitcharoen K, Yansukon P, Wasi P, Fucharoen S, Charoenlarp P, Brittenham G, Pippard MJ, Finch CA: The effect of erythroid hyperplasia on iron balance. Blood. 1988, 71: 1124-1129.
CAS
PubMed
Google Scholar
Tanno T, Miller JL: Iron loading and overloading due to ineffective erythropoiesis. Adv Hematol. 2010, 2010: 358283-10.1155/2010/358283.
Article
PubMed
PubMed Central
Google Scholar
Taher A, Isma’eel H, Mehio G, Bignamini D, Kattamis A, Rachmilewitz EA, Cappellini MD: Prevalence of thromboembolic events among 8,860 patients with thalassaemia major and intermedia in the Mediterranean area and Iran. Thromb Haemost. 2006, 96: 488-491.
CAS
PubMed
Google Scholar
Taher AT, Musallam KM, Karimi M, El-Beshlawy A, Belhoul K, Daar S, Saned M, Cesaretti C, Cappellini MD: Splenectomy and thrombosis: the case of thalassemia intermedia. J Thromb Haemost. 2010, 8: 2152-2158. 10.1111/j.1538-7836.2010.03940.x.
Article
CAS
PubMed
Google Scholar
Viprakasit V, Tanphaichitr VS, Chinchang W, Sangkla P, Weiss MJ, Higgs DR: Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. Blood. 2004, 103: 3296-3299. 10.1182/blood-2003-11-3957.
Article
CAS
PubMed
Google Scholar
Laosombat V, Viprakasit V, Chotsampancharoen T, Wongchanchailert M, Khodchawan S, Chinchang W, Sattayasevana B: Clinical features and molecular analysis in Thai patients with HbH disease. Ann Hematol. 2009, 88: 1185-1192. 10.1007/s00277-009-0743-5.
Article
CAS
PubMed
Google Scholar
Fucharoen S, Viprakasit V: Hb H disease: clinical course and disease modifiers.Hematology Am Soc Hematol Educ Program 2009:26-34.,
Olivieri NF: Treatment strategies for hemoglobin E beta-thalassemia. Blood Rev. 2012, 26 (Suppl 1): S28-S30. 10.1016/S0268-960X(12)70009-7.
Article
CAS
PubMed
Google Scholar
Viprakasit V, Tanphaichitr VS, Mahasandana C, Assteerawatt A, Suwantol L, Veerakul G, Kankirawatana S, Pung-Amritt P, Suvatte V: Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens. J Med Assoc Thai. 2001, 84: 929-941.
CAS
PubMed
Google Scholar
Yin XL, Zhang XH, Wu ZK, Zhao DH, Zhou YL, Yu YH, Liu TN, Fang SP, Zhou TH, Wang L, Huang J: Pulmonary hypertension risk in patients with hemoglobin H disease: low incidence and absence of correlation with splenectomy. Acta Haematol. 2013, 130: 153-159. 10.1159/000347177.
Article
CAS
PubMed
Google Scholar
Viprakasit V, Sawathiparnich P, Sangpraypanm T, Weerakulwattana L, Kiattisakthavee P, Chaichanwatanakul K, Vatana N: Osteopenia is commonly present in prepubertal children with severe Hb E/thalassemia despite adequate transfusion and iron chelation therapy. ASH Annual Meeting Abstracts. 2007, 110: 3830-
Google Scholar
Taher A, Vichinsky E, Musallam KM, Cappellini MD, Viprakasit V: Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT). 2013, Nicosia, Thalassemia International Federation
Google Scholar
Tso SC, Loh TT, Todd D: Iron overload in patients with haemoglobin H disease. Scand J Haematol. 1984, 32: 391-394. 10.1111/j.1600-0609.1984.tb00694.x.
Article
CAS
PubMed
Google Scholar
Viprakasit V: Alpha thalassemia syndromes: from clinical and molecular diagnosis to bedside management. EHA Hematol Educ Program. 2013, 7: 329-338.
Google Scholar
Musallam KM, Rivella S, Vichinsky E, Rachmilewitz EA: Non-transfusion-dependent thalassemias. Haematologica. 2013, 98: 833-844. 10.3324/haematol.2012.066845.
Article
CAS
PubMed
PubMed Central
Google Scholar
The thalassaemia working party of the BCSH general haematology task force. J Clin Pathol. 1994, 47: 289-295. 10.1136/jcp.47.4.289.
The laboratory diagnosis of haemoglobinopathies. Br J Haematol. 1998, 101: 783-792. 10.1046/j.1365-2141.1998.00809.x.
Fucharoen G, Sanchaisuriya K, Sae-ung N, Dangwibul S, Fucharoen S: A simplified screening strategy for thalassaemia and haemoglobin E in rural communities in south-east Asia. Bull World Health Organ. 2004, 82: 364-372.
PubMed
PubMed Central
Google Scholar
O’Riordan S, Hien TT, Miles K, Allen A, Quyen NN, Hung NQ, Anh DQ, Tuyen LN, Khoa DB, Thai CQ, Triet DM, Phu NH, Dunstan S, Peto T, Clegg J, Farrar J, Weatherall D: Large scale screening for haemoglobin disorders in southern Vietnam: implications for avoidance and management. Br J Haematol. 2010, 150: 359-364. 10.1111/j.1365-2141.2010.08237.x.
Article
PubMed
Google Scholar
Taher AT, Musallam KM, Nasreddine W, Hourani R, Inati A, Beydoun A: Asymptomatic brain magnetic resonance imaging abnormalities in splenectomized adults with thalassemia intermedia. J Thromb Haemost. 2010, 8: 54-59. 10.1111/j.1538-7836.2009.03651.x.
Article
CAS
PubMed
Google Scholar
Musallam KM, Khoury B, Bi-Habib R, Bazzi L, Succar J, Halawi R, Hankir A, Koussa S, Taher AT: Health-related quality of life in adults with transfusion-independent thalassaemia intermedia compared to regularly transfused thalassaemia major: new insights. Eur J Haematol. 2011, 87: 73-79. 10.1111/j.1600-0609.2011.01623.x.
Article
PubMed
Google Scholar
Taher A, Hershko C, Cappellini MD: Iron overload in thalassaemia intermedia: reassessment of iron chelation strategies. Br J Haematol. 2009, 147: 634-640. 10.1111/j.1365-2141.2009.07848.x.
Article
CAS
PubMed
Google Scholar
Dixit A, Chatterjee TC, Mishra P, Choudhry DR, Mahapatra M, Tyagi S, Kabra M, Saxena R, Choudhry VP: Hydroxyurea in thalassemia intermedia-a promising therapy. Ann Hematol. 2005, 84: 441-446. 10.1007/s00277-005-1026-4.
Article
CAS
PubMed
Google Scholar
Karimi M, Darzi H, Yavarian M: Hematologic and clinical responses of thalassemia intermedia patients to hydroxyurea during 6 years of therapy in Iran. J Pediatr Hematol Oncol. 2005, 27: 380-385. 10.1097/01.mph.0000174386.13109.28.
Article
PubMed
Google Scholar
Singer ST, Kuypers FA, Olivieri NF, Weatherall DJ, Mignacca R, Coates TD, Davies S, Sweeters N, Vichinsky EP: Fetal haemoglobin augmentation in E/beta (0) thalassaemia: clinical and haematological outcome. Br J Haematol. 2005, 131: 378-388. 10.1111/j.1365-2141.2005.05768.x.
Article
CAS
PubMed
Google Scholar
Ansari SH, Shamsi TS, Munzir S, Khan MT, Erum S, Perveen K, Farzana T, Ashraf M, Mehboob T, Moinuddin M: Ggamma-Xmn I polymorphism: a significant determinant of beta-thalassemia treatment without blood transfusion. J Pediatr Hematol Oncol. 2013, 35: e153-e156. 10.1097/MPH.0b013e31827e8662.
Article
CAS
PubMed
Google Scholar
Sharma N, Das R, Kaur J, Ahluwalia J, Trehan A, Bansal D, Panigrahi I, Marwaha RK: Evaluation of the genetic basis of phenotypic heterogeneity in north Indian patients with thalassemia major. Eur J Haematol. 2010, 84: 531-537. 10.1111/j.1600-0609.2010.01422.x.
Article
CAS
PubMed
Google Scholar
Taher A, El Rassi F, Isma’eel H, Koussa S, Inati A, Cappellini MD: Correlation of liver iron concentration determined by R2 magnetic resonance imaging with serum ferritin in patients with thalassemia intermedia. Haematologica. 2008, 93: 1584-1586. 10.3324/haematol.13098.
Article
CAS
PubMed
Google Scholar
Taher AT, Musallam KM, Wood JC, Cappellini MD: Magnetic resonance evaluation of hepatic and myocardial iron deposition in transfusion-independent thalassemia intermedia compared to regularly transfused thalassemia major patients. Am J Hematol. 2010, 85: 288-290. 10.1002/ajh.21626.
Article
CAS
PubMed
Google Scholar
Taher AT, Viprakasit V, Musallam KM, Cappellini MD: Treating iron overload in patients with non-transfusion-dependent thalassemia. Am J Hematol. 2013, 88: 409-415. 10.1002/ajh.23405.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ladis V, Berdousi H, Gotsis E, Kattamis A: Deferasirox administration for the treatment of non-transfusional iron overload in patients with thalassaemia intermedia. Br J Haematol. 2010, 151: 504-508. 10.1111/j.1365-2141.2010.08346.x.
Article
CAS
PubMed
Google Scholar
Pootrakul P, Sirankapracha P, Sankote J, Kachintorn U, Maungsub W, Sriphen K, Thakernpol K, Atisuk K, Fucharoen S, Chantraluksri U, Shalev O, Hoffbrand AV: Clinical trial of deferiprone iron chelation therapy in beta-thalassaemia/haemoglobin E patients in Thailand. Br J Haematol. 2003, 122: 305-310. 10.1046/j.1365-2141.2003.04412.x.
Article
CAS
PubMed
Google Scholar
Taher AT, Porter J, Viprakasit V, Kattamis A, Chuncharunee S, Sutcharitchan P, Siritanaratkul N, Galanello R, Karakas Z, Lawniczek T, Ros J, Zhang Y, Habr D, Cappellini MD: Deferasirox reduces iron overload significantly in nontransfusion-dependent thalassemia: 1-year results from a prospective, randomized, double-blind, placebo-controlled study. Blood. 2012, 120: 970-977. 10.1182/blood-2012-02-412692.
Article
CAS
PubMed
Google Scholar
Cappellini MD, Robbiolo L, Bottasso BM, Coppola R, Fiorelli G, Mannucci AP: Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000, 111: 467-473. 10.1046/j.1365-2141.2000.02376.x.
Article
CAS
PubMed
Google Scholar
Bisharat N, Omari H, Lavi I, Raz R: Risk of infection and death among post-splenectomy patients. J Infect. 2001, 43: 182-186. 10.1053/jinf.2001.0904.
Article
CAS
PubMed
Google Scholar
Olivieri NF, Muraca GM, O’Donnell A, Premawardhena A, Fisher C, Weatherall DJ: Studies in haemoglobin E beta-thalassaemia. Br J Haematol. 2008, 141: 388-397. 10.1111/j.1365-2141.2008.07126.x.
Article
CAS
PubMed
Google Scholar